Rita Murri

Summary

Country: Italy

Publications

  1. ncbi request reprint Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART
    Giovanni Guaraldi
    Department of Medical and Surgery Specialities, Infectious Diseases Clinic, University of Modena and Reggio Emilia School of Medicine, Italy
    HIV Clin Trials 4:99-106. 2003
  2. ncbi request reprint Sexual dysfunction in HIV-infected men: role of antiretroviral therapy, hypogonadism and lipodystrophy
    Giovanni Guaraldi
    Universita di Modena e Reggio Emilia, Modena, Italy
    Antivir Ther 12:1059-65. 2007
  3. ncbi request reprint Patient-reported nonadherence to HAART is related to protease inhibitor levels
    R Murri
    Department of Infectious Diseases, Catholic University of Rome, Italy
    J Acquir Immune Defic Syndr 24:123-8. 2000
  4. ncbi request reprint Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors
    R Murri
    Department of Infectious Diseases, Catholic University, Rome, Italy
    J Acquir Immune Defic Syndr 22:461-6. 1999
  5. ncbi request reprint Incidence and determinants of bacterial infections in HIV-positive patients receiving anti-Pneumocystis carinii/Toxoplasma gondii primary prophylaxis within a randomized clinical trial
    R Murri
    Department of Infectious Diseases, Catholic University, Rome, Italy
    J Acquir Immune Defic Syndr 27:49-55. 2001
  6. ncbi request reprint Self-reported nonadherence with antiretroviral drugs predicts persistent condition
    R Murri
    Department of Infectious Diseases, Catholic University of Rome, Italy
    HIV Clin Trials 2:323-9. 2001
  7. ncbi request reprint Physician estimates of adherence and the patient-physician relationship as a setting to improve adherence to antiretroviral therapy
    Rita Murri
    Clinica delle Malattie Infettive, Universita Cattolica del S Cuore, Roma, Italy
    J Acquir Immune Defic Syndr 31:S158-62. 2002
  8. ncbi request reprint Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART
    Andrea Antinori
    Istituto Nazionale per le Malattie Infettive, L Spallanzani IRCCS, Roma, Italy
    Antivir Ther 9:291-6. 2004
  9. doi request reprint Rate and predictors of self-chosen drug discontinuations in highly active antiretroviral therapy-treated HIV-positive individuals
    Rita Murri
    Department of Infectious Diseases, Catholic University of Rome, Rome, Italy
    AIDS Patient Care STDS 23:35-9. 2009
  10. doi request reprint Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals
    Maria Paola Trotta
    Istituto Nazionale per le Malattie Infettive, L Spallanzani IRCCS, Rome, Italy
    AIDS Patient Care STDS 22:291-9. 2008

Collaborators

Detail Information

Publications29

  1. ncbi request reprint Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART
    Giovanni Guaraldi
    Department of Medical and Surgery Specialities, Infectious Diseases Clinic, University of Modena and Reggio Emilia School of Medicine, Italy
    HIV Clin Trials 4:99-106. 2003
    ..To evaluate the association between adherence to drugs and morphologic alterations (MOA) in a cohort of HIV-infected patients on HAART...
  2. ncbi request reprint Sexual dysfunction in HIV-infected men: role of antiretroviral therapy, hypogonadism and lipodystrophy
    Giovanni Guaraldi
    Universita di Modena e Reggio Emilia, Modena, Italy
    Antivir Ther 12:1059-65. 2007
    ..Both psychological and organic factors have been recognized to be associated with sexual dysfunction in HIV-infected individuals...
  3. ncbi request reprint Patient-reported nonadherence to HAART is related to protease inhibitor levels
    R Murri
    Department of Infectious Diseases, Catholic University of Rome, Italy
    J Acquir Immune Defic Syndr 24:123-8. 2000
    ..To compare self-reported nonadherence with antiretroviral therapy (ART) with predose plasma levels of protease inhibitor (PI)...
  4. ncbi request reprint Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors
    R Murri
    Department of Infectious Diseases, Catholic University, Rome, Italy
    J Acquir Immune Defic Syndr 22:461-6. 1999
    ..To assess rates of prescriptions of protease inhibitors (PI) and determinants of not being prescribed PIs in a cohort of HIV-infected people eligible (according to published guidelines) for highly active antiretroviral therapy (HAART)...
  5. ncbi request reprint Incidence and determinants of bacterial infections in HIV-positive patients receiving anti-Pneumocystis carinii/Toxoplasma gondii primary prophylaxis within a randomized clinical trial
    R Murri
    Department of Infectious Diseases, Catholic University, Rome, Italy
    J Acquir Immune Defic Syndr 27:49-55. 2001
    ..82; p <.05 and HR, 10.15; p <.05, respectively). In conclusion, CTX at the dosage employed for primary PCP/TE prophylaxis does not seem to protect against bacterial infections more than second-line DP...
  6. ncbi request reprint Self-reported nonadherence with antiretroviral drugs predicts persistent condition
    R Murri
    Department of Infectious Diseases, Catholic University of Rome, Italy
    HIV Clin Trials 2:323-9. 2001
    ..To assess variables predictive of nonadherence persisting over time in HIV-infected people treated with highly active antiretroviral therapy...
  7. ncbi request reprint Physician estimates of adherence and the patient-physician relationship as a setting to improve adherence to antiretroviral therapy
    Rita Murri
    Clinica delle Malattie Infettive, Universita Cattolica del S Cuore, Roma, Italy
    J Acquir Immune Defic Syndr 31:S158-62. 2002
    ..Active patient participation in the decision-making process is crucial...
  8. ncbi request reprint Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART
    Andrea Antinori
    Istituto Nazionale per le Malattie Infettive, L Spallanzani IRCCS, Roma, Italy
    Antivir Ther 9:291-6. 2004
    ..6%) experienced virological rebound by 96 weeks. Both self-reported non-adherence and sub-optimal concentration were independently associated with a higher risk of virological rebound...
  9. doi request reprint Rate and predictors of self-chosen drug discontinuations in highly active antiretroviral therapy-treated HIV-positive individuals
    Rita Murri
    Department of Infectious Diseases, Catholic University of Rome, Rome, Italy
    AIDS Patient Care STDS 23:35-9. 2009
    ..The rate of self-chosen TI was high and often related to suboptimal adherence. These findings may help clinicians to better monitor patients, and identify patients for targeted counseling...
  10. doi request reprint Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals
    Maria Paola Trotta
    Istituto Nazionale per le Malattie Infettive, L Spallanzani IRCCS, Rome, Italy
    AIDS Patient Care STDS 22:291-9. 2008
    ..44; 95% CI 1.30-9.08). In conclusion, patients' perceived SD represents a relevant problem for HIV-infected persons treated with antiretrovirals and is strongly associated with suboptimal HAART adherence...
  11. ncbi request reprint Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons
    Adriana Ammassari
    Clinica delle Malattie Infettive, Universita Cattolica del Sacro Cuore, Rome, Italy
    Psychosomatics 45:394-402. 2004
    ..59, 95% CI=1.05-6.39), and complaints about impairment of sexual activity (odds ratio=6.62, 95% CI=1.16-37.6). The presence of depressive symptoms, but not neurocognitive impairment, was associated with nonadherence...
  12. ncbi request reprint Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance
    Andrea De Luca
    Institute of Clinical Infectious Diseases, Catholic University, Rome, Italy
    J Infect Dis 187:1934-43. 2003
    ..GSSs predicted changes in HIV RNA levels better in adherent patients than in nonadherent individuals. Interpretation may be improved, and knowledge should be used uniformly throughout different expert systems...
  13. ncbi request reprint Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from the Italian cohort of antiretroviral-naive patients study
    Rita Murri
    Istituto di Clinica delle Malattie Infettive, Università Cattolica S Cuore of Rome, Rome, Italy
    J Acquir Immune Defic Syndr 41:23-30. 2006
    ....
  14. doi request reprint Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia
    Nicoletta Ciccarelli
    Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy
    Antivir Ther 18:153-60. 2013
    ..The objective of our study was to compare two different central nervous system penetration-effectiveness (CPE) scores for the prediction of cognitive dysfunction in HIV-infected patients...
  15. pmc Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance
    Rita Murri
    Clinica delle Malattie Infettive, Universita Cattolica del S Cuore, 00168 Rome, Italy
    J Gen Intern Med 19:1104-10. 2004
    ..To evaluate the rate of discordance between patients and physicians on adherence to highly active antiretroviral therapy (HAART) and identify factors related to discordance in these two assessments...
  16. ncbi request reprint Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature
    Adriana Ammassari
    Clinica delle Malattie Infettive, Universita Cattolica del S Cuore, Roma, Italy
    J Acquir Immune Defic Syndr 31:S123-7. 2002
    ..These limitations concern the measurement of adherence, the assessment of correlates and predictors of adherence, the study population, and the study design...
  17. doi request reprint Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir an
    Simona Di Giambenedetto
    Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy
    J Antimicrob Chemother 68:1364-72. 2013
    ..To explore 48 week safety and efficacy of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression on a stable atazanavir/ritonavir-based standard triple regimen...
  18. doi request reprint Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma
    Antonella Cingolani
    Institute of Infectious Diseases, Catholic University, Rome, Italy
    AIDS 24:2408-12. 2010
    ....
  19. ncbi request reprint Access to antiretroviral treatment, incidence of sustained therapy interruptions, and risk of clinical events according to sex: evidence from the I.Co.N.A. Study
    Rita Murri
    Department of Infectious Diseases, Catholic University of Rome, Italy
    J Acquir Immune Defic Syndr 34:184-90. 2003
    ..3). Clinical progression was observed in 53 women (22.6%) and 137 men (23.4%; P = 0.56). Risk of developing a clinical event was found to be no different between women and men (relative hazard = 0.84, 95% CI: 0.56-1.26; P = 0.40)...
  20. ncbi request reprint Facial lipohypertrophy in HIV-infected subjects who underwent autologous fat tissue transplantation
    Giovanni Guaraldi
    Clinica delle Malattie Infettive, Universita degli Studi di Modena e Reggio Emilia, Modena, Italy
    Clin Infect Dis 40:e13-5. 2005
    ....
  21. doi request reprint Management of recurrent cutaneous abscesses during therapy with infliximab
    Clara De Simone
    Department of Dermatology, Catholic University of Sacred Heart, Rome, Italy
    Clin Ther 33:1993-6. 2011
    ....
  22. pmc Highly active antiretroviral therapy
    Rita Murri
    BMJ 330:681-2. 2005
  23. ncbi request reprint Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy
    Fabrizio Starace
    Servizio Psichiatria di Consultazione ed Epidemiologia Comportamentale, Ospedale D Cotugno, Napoli, Italy
    J Acquir Immune Defic Syndr 31:S136-9. 2002
    ....
  24. ncbi request reprint Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)
    Antonella Cingolani
    Istituto di Clinica delle Malattie Infettive, Universita Cattolica del Sacro Cuore, Largo Agostino Gemelli 8, 00168 Rome, Italy
    AIDS 16:369-79. 2002
    ....
  25. pmc Severity of lipodystrophy is associated with decreased health-related quality of life
    Giovanni Guaraldi
    Department of Medicine and Medical Specialties, Infectious Diseases Clinic, University of Modena and Reggio Emilia, Modena, Italy
    AIDS Patient Care STDS 22:577-85. 2008
    ..HRQOL was strongly correlated with LD severity when a patient-based score was used. For an overall assessment of the impact of LD on HIV-infected people, both patient-based and physician-based measures are required...
  26. ncbi request reprint Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapy
    Laura Aian Gillini
    J Acquir Immune Defic Syndr 29:546-7. 2002
  27. ncbi request reprint Is "once-daily" regimen a key strategy for improving adherence to antiretroviral regimens?
    Rita Murri
    J Acquir Immune Defic Syndr 42:259-60. 2006
  28. ncbi request reprint Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the Italian Cohort of Antiretroviral-Naive Patients
    Antonella d'Arminio Monforte
    Istituto di Malattie Infettive e Tropicali, Universita di Milano, Milano, Italy
    J Acquir Immune Defic Syndr 38:407-16. 2005
    ....
  29. ncbi request reprint Sexual dysfunction in HIV infection
    Maria Paola Trotta
    Lancet 369:905-6. 2007